Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients.
OBJECTIVE
We investigated the characteristics of recent male and female patients diagnosed with interstitial cystitis (IC), then investigated which therapy was chosen by the attending urologist.


METHODS
Materials were 282 IC patients diagnosed and treated during the past 3 years (sampling from Japanese IC database). Gender, age, medical history and predominant symptoms were investigated. In addition, we investigated the interval before a diagnosis was established. In laboratory findings, we investigated voided volume, urinalysis findings and cystoscopic findings. Regarding therapy, we investigated which therapy was chosen as the first line.


RESULTS
The gender ratio was about 1.0:5.6 (male : female). Regarding age distribution, patients in their 60s were the most frequent (65 cases, 31.3%). The interval before diagnosis of IC was 36.5 months on average (1-360 months). Regarding medical history, intrapelvic surgery was the most common and repeated urinary tract infection was next. The most frequent symptom was urinary frequency (295 cases, 98.3%). Urinary urgency was noted in 186 cases (62%) and supra-pubic pain was noted in 125 cases (41.6%). The once voided volume was 104.3 mL on average (50-200 mL). The most common cystoscopic finding was glomerulation (158 cases). Ulcer was present in only 19 cases. The most widely carried out therapy was hydrodistension (208 cases, 67.9%). Oral suplatast tosilate (197 cases, 65.6%), antihistamine (77 cases, 25.6%) and intravesical dimethylsulfoxide (69 cases, 23%) followed.


CONCLUSIONS
Regarding characteristics, the age distribution was older than other countries. The most frequent symptom was urinary frequency. Oral suplatast tosilate was one of the popular therapies in Japan.
Ito
Takaaki
T
Department of Urology, Tokyo Medical University Kasumigaura Hospital, Tokyo, Japan. takaaki@tokyo-med.ac.jp
Ueda
Tomohiro
T
Honma
Yukio
Y
Takei
Mineo
M
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001190:Arylsulfonates / Q000627:therapeutic use; D044466:Asian People; D018856:Cystitis, Interstitial / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008487:Medical History Taking; D008875:Middle Aged; D017678:Sex Distribution; D013452:Sulfonium Compounds / Q000627:therapeutic use
D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D001190:Arylsulfonates; D013452:Sulfonium Compounds; C073028:suplatast tosilate